ARLINGTON, Va., Sept. 11, 2019 /PRNewswire/ -- A new report released today by the National Osteoporosis Foundation (NOF) finds that despite the existence of proven preventive measures, approximately 2 million Americans on Medicare suffered 2.3 million osteoporosis-related bone fractures in 2015. These totals mean osteoporotic fractures are responsible for more hospi

PHOENIX, Sept. 11, 2019 /PRNewswire/ -- Creative Medical Technology Holdings (OTC-CELZ) reported today it has signed an agreement with Edge Media Network to introduce CaverStem® to their community in an integrated campaign spanning web, email, social media, and in-person events.

SEATTLE, Sept. 11, 2019 /PRNewswire/ -- Immunexpress, Inc. today announced that Jane Papadaki Markley has joined the company's Executive Team as Vice President of

DURHAM, North Carolina and NEW YORK, Sept. 11, 2019 /PRNewswire/ -- Dance Biopharm Holdings, Inc., a clinical-stage company reimagining the treatment of chronic diseases with inhaled therapies, announced today it has formed a strategic alliance with

REYKJAVIK, Iceland, Sept. 11, 2019 /PRNewswire/ -- An article published in the journal Nature Medicine reports that two above knee lower-limb amputees who had intraneural electrodes implanted in their thighs and wore Össur prosthetic componentry are the first in the world to "feel" their prosthetic foot and knee in real-time.  In the article, "

CAMPBELL, Calif., Sept. 11, 2019 /PRNewswire/ -- Atia Vision, Inc., a Shifamed portfolio company committed to improving patient outcomes through the development of a novel modular presbyopia-correcting intraocular lens (IOL), today announced its technology will be featured in presentations at two ophthalmology conferences this week in Paris

PRINCETON, N.J., Sept. 11, 2019 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that it has appointed Jonathan Guarino, as its Senior Vice Pres

BOCA RATON, Fla., Sept. 11, 2019 /PRNewswire/ -- Arcline Investment Management ("Arcline"), a growth oriented private equity firm with $1.5 billion of capital under management, today announced that it has acquired a majority interest in Akron Biotechnology LLC ("Akron" or "The Company"). Akron will continue to be led by Claudia Zylberberg

AMSTERDAM, Sept. 11, 2019 /PRNewswire/ -- At the 4th Annual European Forum on Nanoscale IR Spectroscopy, Bruker (Nasdaq: BRKR) today announced the release of the nanoIR3-s Broadband™, the most advanced nanoscale FTIR spectroscopy system available to researchers. The system combines Bruker's industry-leading, high-performance, nanoIR3-s

LOS ANGELES, Sept. 11, 2019 /PRNewswire/ -- O&O Academy today announced it will hold its 2nd annual